By modulating this pathway ketamine (in a mouse model of post-stroke depression) can restore dendritic spine density and the expression of synaptic proteins such as PSD-95 and SYP during stroke induced neurological damage [31]. The gene discussed is DLG4; the disease is stroke disorder.